Laboratory Corp. investors, led by Longview, increase stake in company to 6.2%

By Lisa Kerner

Charlotte, N.C., March 2 - Laboratory Corp. of America Holdings investors led by Longview Asset Management, LLC purchased 448,437 shares of the company's stock from Feb. 15 through March 1 priced between $71.39 and $79.51 per share, according to a schedule 13D filing with the Securities and Exchange Commission.

Longview representatives have discussed the business operations and assets with Laboratory Corp. management and may continue to communicate with the management, as well as with other shareholders and the board of directors, in the future, according to the filing.

The reporting persons beneficially own 7,584,731 shares, or 6.2%, of the Burlington, N.C.-based medical testing company's outstanding shares.

Laboratory Corp. stock (NYSE: LH) closed at $70.17 on March 1.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.